Crispr Therapeutics shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.5M | 32k | 46.98 |
| 2024-06-30 | $2.1M | 38k | 54.01 |
| 2024-03-31 | $2.4M | 35k | 68.16 |
| 2023-12-31 | $2.0M | 32k | 62.60 |
| 2023-09-30 | $1.3M | 29k | 45.39 |
| 2023-06-30 | $1.6M | 29k | 56.14 |
| 2023-03-31 | $2.6M | 57k | 45.23 |
| 2022-12-31 | $1.8M | 43k | 40.65 |
| 2022-09-30 | $2.4M | 37k | 65.36 |
| 2022-06-30 | $2.0M | 33k | 60.77 |
| 2022-03-31 | $3.2M | 52k | 62.76 |
| 2021-12-31 | $4.6M | 60k | 75.78 |
| 2021-09-30 | $9.8M | 88k | 111.93 |
| 2021-06-30 | $13M | 79k | 161.89 |
| 2021-03-31 | $7.6M | 62k | 121.85 |
| 2020-12-31 | $9.4M | 62k | 153.10 |
| 2020-09-30 | $4.9M | 59k | 83.65 |
| 2020-06-30 | $4.1M | 55k | 73.48 |
| 2020-03-31 | $2.4M | 56k | 42.41 |
| 2019-12-31 | $3.1M | 51k | 60.90 |
| 2019-09-30 | $2.3M | 55k | 41.00 |
| 2019-06-30 | $2.5M | 53k | 47.11 |
| 2019-03-31 | $1.8M | 52k | 35.72 |
| 2018-12-31 | $1.4M | 49k | 28.56 |
| 2018-09-30 | $1.9M | 43k | 44.36 |
| 2018-06-30 | $4.8M | 82k | 58.76 |
| 2018-03-31 | $3.8M | 82k | 45.71 |
| 2017-12-31 | $1.9M | 83k | 23.48 |
| 2017-09-30 | $870k | 49k | 17.88 |
| 2017-06-30 | $321k | 20k | 16.04 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates